Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Ottawa Heart Institute Research Corporation

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Ottawa Heart Institute Research Corporation

RECRUITINGPhase 2 / Phase 3NCT05253794

Effect of Colchicine on the Progression of Aortic Valve Stenosis - a Pilot Study

COPAS pilot is a pilot single center double blinded randomized study to determine the effect of targeted anti-inflammation therapy using colchicine, on valvular calcification...

Sponsor: Ottawa Heart Institute Research CorporationEnrolling: 241 location
Aortic StenosisInflammation
RECRUITINGPhase 4NCT05267886

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

The investigators are interested in determining if there is a meaningful benefit from the use of medications purported to increase the pumping function of the heart (i.e....

Sponsor: Ottawa Heart Institute Research CorporationEnrolling: 3463 locations
Shock, Cardiogenic
RECRUITINGNCT01477359

Cardiac Sarcoidosis Multi-Center Prospective Cohort

Recent data has shown that sarcoidosis, presenting initially with cardiac manifestations (CS) of either conduction system disease or cardiomyopathy and sustained VT, is not...

Sponsor: Ottawa Heart Institute Research CorporationEnrolling: 150014 locations
Cardiac Sarcoidosis
RECRUITINGPhase 3NCT03593759

Cardiac Sarcoidosis Randomized Trial

Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed...

Sponsor: Ottawa Heart Institute Research CorporationEnrolling: 19420 locations
Cardiac SarcoidosisSarcoidosis
RECRUITINGNCT05632601

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study

The full HER CROWN will be a prospective cohort study to propose a novel, women-specific cardiovascular risk score/ algorithm in the prediction of hard cardiovascular outcomes...

Sponsor: Ottawa Heart Institute Research CorporationEnrolling: 2101 location
Cardiovascular Diseases